Attenuated vaccines can recombine to form virulent field viruses. - Wikidata - awgldk - TriplyDB

Attenuated vaccines can recombine to form virulent field viruses.

Attenuated vaccines can recombine to form virulent field viruses.

http://www.wikidata.org/entity/Q34288335

about

Immune mechanisms in malaria: new insights in vaccine development Progress and challenges toward the development of vaccines against avian infectious bronchitis Avian influenza: virology, diagnosis and surveillance.Third generation sequencing technologies applied to diagnostic microbiology: benefits and challenges in applications and data analysis.Tackling animal diseases to protect human health. As veterinary science celebrates cattle plague eradication, the inextricable link between human, animal and ecosystem health is increasingly appreciated.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Phylogenetic and molecular epidemiological studies reveal evidence of multiple past recombination events between infectious laryngotracheitis viruses.Complete genome sequence of the first Chinese virulent infectious laryngotracheitis virus.Growth kinetics and transmission potential of existing and emerging field strains of infectious laryngotracheitis virus Multiple Comparison Analysis of Two New Genomic Sequences of ILTV Strains from China with Other Strains from Different Geographic Regions.Recombination of Globally Circulating Varicella-Zoster Virus Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy Low genetic diversity among historical and contemporary clinical isolates of felid herpesvirus 1.Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds.Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.Worldwide circulation of HSV-2 × HSV-1 recombinant strains.Challenges and recent advancements in infectious laryngotracheitis virus vaccines.Vaccines based on structure-based design provide protection against infectious diseases.Molecular epidemiology of infectious laryngotracheitis: a review.In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity.Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1 Investigation of a Possible Link Between Vaccination and the 2010 Sheep Pox Epizootic in Morocco.An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.Chicken embryo origin-like strains are responsible for Infectious laryngotracheitis virus outbreaks in Egyptian cross-bred broiler chickens.Global distributions and strain diversity of avian infectious bronchitis virus: a review.Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.Genotyping of infectious laryngotracheitis virus using allelic variations from multiple genomic regions.Current Status of Rift Valley Fever Vaccine Development.Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.The Impacts of Genome-wide Analyses on our Understanding of Human Herpesvirus Diversity and Evolution.Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?Full-Genome Sequence of Infectious Laryngotracheitis Virus (Gallid Alphaherpesvirus 1) Strain VFAR-043, Isolated in Peru.A gel-based PCR method to differentiate sheeppox virus field isolates from vaccine strains.

P2860

Q21032484-339ED0A8-AC6D-48D8-AA7A-2F7DFA9CCE65 Q27015837-933D9EE9-E4BE-4422-A39F-D84494D38646 Q30353483-FE376BC2-655B-4961-B57A-CFA24934B874 Q31117238-3612230C-1DA0-436F-9FA2-4F7A650EC3E3 Q34316911-261361F0-4F16-4602-8025-3E79E2A983A7 Q34349745-CB4F9534-D660-47E3-87D0-31EBBC8F4742 Q34577058-77FF8366-8B21-4DB3-8F2A-BD0EBF4E60A7 Q34906326-D07346F7-F1ED-4B87-B03B-91F4FE23E57A Q35192770-284540A7-62A2-4A35-B2BC-2AE5249F291F Q35694654-B80CECF7-DEBC-419B-BB1C-66664548B33B Q35758661-901147E7-5633-44E0-9387-2B41B29CF598 Q35772273-3ADF5FC5-0305-4D14-8570-282F5F9F3AC5 Q35927223-3FA2BCB9-E921-4D6B-80D3-B5B075F93536 Q36121891-3E624255-56D8-4133-A128-0DD0A5810EAB Q36132147-4C6E24CC-0CE8-4C1E-A5D6-60F59FF95C8B Q36325388-70FB13C5-EA06-49DF-A156-A7DBD9152753 Q36738542-0FF4661A-F8E3-47D6-8BAC-D3538CB3DFD0 Q36765590-B101492E-5059-480F-A92A-3734389FC319 Q37254943-61A654A8-7A3D-46EE-8730-6780C6109961 Q37532874-2477A55B-8F60-44D0-99EC-2A070D4799E3 Q37695200-D268D517-C8D2-4A46-9743-5EFAB81AFB75 Q38110339-1055A345-021F-4444-A378-29087CF4CE5F Q38148782-3E9CAF9A-8934-4984-B668-7F1F20AE4CA9 Q38181551-8DA71A0A-8DD9-4879-B5BA-B1BB4E9BC006 Q38414056-057492D1-C43D-45BE-8CD7-0A4B878EBB18 Q38848322-53D60AE7-D780-4E47-85DB-A65B9B750690 Q38929399-C71B398E-CF43-4B5F-8827-EA1D5BE05246 Q39040685-212A78A6-A358-4D61-9B8A-1C9F9E0AD11B Q39227077-9CFE1EB1-4A98-439B-B52A-D34C6CA87AF8 Q39454438-F7364E57-8049-422B-9EF1-521F73D0383C Q40094937-ED9F8AFC-7D1D-4DD5-859E-DD533FEEB1B1 Q40757072-3A7ECED5-8E16-4017-8208-48D574866D50 Q40762791-814DC3B4-CE95-4BA2-85BA-C47592E1BA11 Q41929716-7A1690DF-86C8-4E81-862B-23F674029959 Q41931848-236B373B-8334-4370-850E-B492BA5B03FE Q42778214-5901EBC1-7704-4349-84C6-552B410EF305 Q44170263-009CEA26-03B3-42FD-BDF0-EE15E3CDDACA Q45325213-BBEBB752-5C58-49E4-836C-EFC161E3489C Q52665826-2D826019-F1E4-47CB-ACDF-B6640AD44C2D Q54975445-F5D77684-13EB-4ECB-B026-F146B7BAE136

P2860

Attenuated vaccines can recombine to form virulent field viruses.

http://www.wikidata.org/entity/Q34288335

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Attenuated vaccines can recombine to form virulent field viruses.

@ast

Attenuated vaccines can recombine to form virulent field viruses.

@en

Attenuated vaccines can recombine to form virulent field viruses.

@nl

type

label

Attenuated vaccines can recombine to form virulent field viruses.

@ast

Attenuated vaccines can recombine to form virulent field viruses.

@en

Attenuated vaccines can recombine to form virulent field viruses.

@nl

prefLabel

Attenuated vaccines can recombine to form virulent field viruses.

@ast

Attenuated vaccines can recombine to form virulent field viruses.

@en

Attenuated vaccines can recombine to form virulent field viruses.

@nl

P1433

Q34288335-F591DF34-8D40-4300-A2DE-BBCFB88A40BF

P1476

Q34288335-830D608A-637E-4BF0-97CB-AEBCCBED2678

P2093

Q34288335-441C07B0-62D2-47BC-95A8-EE5C311C2EBE

Q34288335-4670AC2D-E429-4E62-AF57-A9F0266579D1

Q34288335-85694A6C-D09C-4D04-A2F2-90D09EEB90B5

Q34288335-934FDE3C-A152-4CFF-A150-FB00232B226E

Q34288335-99D9F622-63D9-46C2-8FA4-0D45F231504B

P2860

Q34288335-05B17D52-AD4E-4CDE-B2D8-757C72756155

Q34288335-3488EAB5-301A-4309-B8FB-9F64BA83C8F8

Q34288335-399D829F-BE5C-4CC6-B0E5-405E7E1C92F0

Q34288335-4DADD28B-2395-41ED-93F9-46C0F7D4D93E

Q34288335-867D2C3D-EF78-4B97-A908-8682F116C144

Q34288335-C52EFF8E-24C0-4E4D-B33F-DB9F7BA68AA6

Q34288335-D7EB6407-9A6B-4CC3-90B8-8DA0F9E6C74C

Q34288335-DAED4C9C-FE29-48C7-B66E-11DD8F93871E

P304

Q34288335-FA793AD3-2A2A-4ED9-9381-D8C6B4B80865

P31

Q34288335-B6A449FA-4164-4D2A-95B3-E5793364E180

P356

Q34288335-F48E4F8F-366B-4016-885A-2281BE0C167E

P407

Q34288335-1A8DFA68-CE8B-439E-81D3-FE848F151813

P433

Q34288335-AAAFABFA-5580-4117-A753-0DC07E8B3F8B

P478

Q34288335-6621338A-1135-441F-9D00-A2C9DF63FA04

P50

Q34288335-35358947-ABD3-4E80-8CEF-6E94116DAB0D

Q34288335-5746AFF9-72A3-4D81-AA98-E9433B81C350

Q34288335-70C9691E-F153-44EF-BEF8-07A7233891E1

Q34288335-A4A0E46F-A8E9-488B-942D-F0F6B43944E1

Q34288335-AFA8947C-8239-47FB-B324-FC1096E8119F

P577

Q34288335-CDC541FE-00AB-4962-BC13-F3BD6E9184D2

P698

Q34288335-BFE8FDEC-431E-4665-A456-D72E93D61A5B

P921

Q34288335-698E9D7E-15AC-4004-A390-E0599A49CA73

P356

SCIENCE.1217134

P1433

P1476

Attenuated vaccines can recombine to form virulent field viruses.

@en

P2093

John F Markham

http://www.w3.org/2001/XMLSchema#string

Mauricio J C Coppo

http://www.w3.org/2001/XMLSchema#string

Nino Ficorilli

http://www.w3.org/2001/XMLSchema#string

Philip F Markham

http://www.w3.org/2001/XMLSchema#string

Sang-Won Lee

http://www.w3.org/2001/XMLSchema#string

P2860

First complete genome sequence of infectious laryngotracheitis virus.

Recombination in alphaherpesviruses.

Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.

Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.

Differentiation of infectious laryngotracheitis virus isolates by restriction fragment length polymorphic analysis of polymerase chain reaction products amplified from multiple genes.

Development of a SYBR Green quantitative polymerase chain reaction assay for rapid detection and quantification of infectious laryngotracheitis virus.

Sequence type analysis and recombinational tests (START).

Epidemiology of recent outbreaks of infectious laryngotracheitis in poultry in Australia

P304

188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1217134

http://www.w3.org/2001/XMLSchema#string

P407

P433

6091

http://www.w3.org/2001/XMLSchema#string

P478

337

http://www.w3.org/2001/XMLSchema#string

P50

Glenn F. Browning

Joanne M. Devlin

Alistair R Legione

Amir H Noormohammadi

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22798607

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine